Success Story: From RFE to Approval - A Biomedical Engineering Scientist's NIW Success Under Premium Processing
Client’s Testimonial:
"I had an excellent experience working with the Chen Immigration team on my EB‑2 NIW petition, which was ultimately approved under premium processing after an RFE. Their team was exceptionally diligent, thorough, and highly organized throughout the entire process. They guided me with clarity through the extensive set of letters and documents required, making a complex application feel manageable and structured. I highly recommend Chen Immigration to anyone pursuing an EB‑2 NIW. Their expertise and professionalism played a key role in the successful approval of my I‑140.”
On March 18th, 2026, we received another EB-2 NIW (National Interest Waiver) approval for a Scientist in the Field of Biomedical Engineering (Approval Notice).
General Field: Biomedical Engineering
Position at the Time of Case Filing: Scientist
Country of Origin: India
State of Residence at the Time of Filing: Massachusetts
Approval Notice Date: March 18th, 2026
Processing Time: 5 months, 8 days (Premium Processing Requested)
Case Summary:
It was a privilege for our team to assist a scientist specializing in biomedical engineering, a Ph.D. in bioengineering holder from India, with this EB-2 NIW petition. In line with our commitment to I-140 clients, we adopted a strategic, case-by-case approach, carefully analyzing the qualifications presented to craft a well-supported petition that highlighted the national importance of advancing novel diagnostic and therapeutic technologies for cardiovascular and respiratory diseases.
Client Background and Proposed Endeavor
As an expert in the field of biomedical engineering, the proposed endeavor is to continue research on developing novel technologies and techniques for biomedical engineering and instrumentation in order to improve the diagnosis, treatment, and management of cardiovascular and respiratory diseases. With advanced training spanning multiple specialized areas within biomedical engineering and translational research, this scientist currently serves at a leading research institution in the United States.
National Significance of the Research
We emphasized that this research is of significant importance and has far-reaching implications for the United States. The work directly addresses critical unmet needs in cardiovascular and respiratory healthcare, conditions that affect millions of Americans and place a substantial burden on the national healthcare system. By advancing innovative biomedical engineering solutions, this research strengthens the country's capacity to improve patient outcomes and quality of care.
Furthermore, these contributions align with broader federal health priorities and have been identified as advancing critical and emerging biotechnology areas, fields essential to U.S. technological leadership, economic prosperity, and national security.
Impressive Credentials and Achievements
To further strengthen the case, we highlighted an exceptional record of achievement. This researcher has authored an impressive portfolio of 15 peer-reviewed journal articles (8 of them first-authored or co-first-authored), 8 conference abstracts (6 of them first-authored), and 1 granted patent. This body of work has been cited 153 times. Furthermore, the research has been supported by the National Institutes of Health (NIH), affirming both the national importance and scientific rigor of the proposed endeavor.
Case Outcome
Considering the strength of the accomplishments and the national importance of the proposed endeavor, we are delighted to share that this NIW petition was approved in over 5 months under a premium process. Despite receiving a Request for Evidence (RFE), our expert team swiftly prepared a thorough and well-supported response that successfully addressed all concerns raised. The pioneering work in biomedical engineering and translational research positions this researcher to make lasting contributions to U.S. healthcare and patient outcomes for years to come.